Zhaoqing Fan
- Cancer Research top 2%
- Breast Cancer Treatment Studies 58
- Cancer Genomics and Diagnostics 15
- Genetics top 2%
- BRCA gene mutations in cancer 31
- Oncology top 5%
- HER2/EGFR in Cancer Research 21
- Cancer-related Molecular Pathways 12
- Cancer Treatment and Pharmacology 9
-
- Breast Lesions and Carcinomas 32
- Pharmacology top 5%
-
- DNA Repair Mechanisms 16
- Cited by
- Cancer ResearchGeneticsOncology
- Partner nations
- ChinaEthiopiaSwitzerland
In The Last Decade
Zhaoqing Fan
104 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 79
- Cancer Research 755
- Genetics 850
- Oncology 821
- Pathology and Forensic Medicine 309
- Pharmacology 136
Countries citing papers authored by Zhaoqing Fan
This map shows the geographic impact of Zhaoqing Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoqing Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoqing Fan more than expected).
Fields of papers citing papers by Zhaoqing Fan
This network shows the impact of papers produced by Zhaoqing Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoqing Fan. The network helps show where Zhaoqing Fan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhaoqing Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 48 | |
| 7 | 2019 | 17 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 24 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 145 | |
| 12 | 2017 | 2 | |
| 13 | 2015 | 25 | |
| 14 | [The study of associations between circulating tumor cells and clinicopathologic characteristics in axillary lymph node positive primary breast cancer]. | 2014 | 2 |
| 15 | [Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients]. | 2013 | 2 |
| 16 | 2012 | 1 | |
| 17 | 2011 | 22 | |
| 18 | 2011 | 29 | |
| 19 | [The clinical research of local recurrence after breast-conserving therapy for breast cancer]. | 2010 | 1 |
| 20 | 2006 | 16 |
About Zhaoqing Fan
Zhaoqing Fan is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 109 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (58 papers), Breast Lesions and Carcinomas (32 papers), BRCA gene mutations in cancer (31 papers), HER2/EGFR in Cancer Research (21 papers), DNA Repair Mechanisms (16 papers), Cancer Genomics and Diagnostics (15 papers), Cancer-related Molecular Pathways (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Cancer Research (755 citations), Genetics (850 citations) and Oncology (821 citations). Zhaoqing Fan has collaborated with scholars based in China, Ethiopia and Switzerland. Frequent co-authors include Yuntao Xie, Benyao Lin, Jinfeng Li, Tie Fan, Tao Ouyang, Tao Ouyang, Tianfeng Wang, Ye Xu, Tianfeng Wang and Tao Fan. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.